MedPath

LIFEVANTAGE AUSTRALIA PTY. LTD.

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

TGA:15

Drug Approvals

MB System (469325)

Product Name
MB System
Approval Date
Nov 19, 2024
TGA

MB Core (467805)

Product Name
MB Core
Approval Date
Nov 8, 2024
TGA

AXIO LO (439890)

Product Name
AXIO LO
Approval Date
Feb 5, 2024
TGA

AXIO (439891)

Product Name
AXIO
Approval Date
Feb 5, 2024
TGA

TimeVantage PM (393862)

Product Name
TimeVantage PM
Approval Date
Aug 12, 2022
TGA

TimeVantage AM (393037)

Product Name
TimeVantage AM
Approval Date
Jul 28, 2022
TGA

AXIO (392405)

Product Name
AXIO
Approval Date
Jul 18, 2022
TGA

AXIO LO (391753)

Product Name
AXIO LO
Approval Date
Jul 4, 2022
TGA

Probio (389095)

Product Name
Probio
Approval Date
May 25, 2022
TGA

Protandim SRT (388571)

Product Name
Protandim SRT
Approval Date
May 17, 2022
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.